Oral Rivaroxaban for Symptomatic Venous Thromboembolism

New England Journal of Medicine - Tập 363 Số 26 - Trang 2499-2510 - 2010
Rupert Bauersachs, Scott D. Berkowitz, Benjamin Brenner, Harry R. Büller1, Hervé Decousus2, Alexander Gallus, Anthonie W.A. Lensing, Frank Misselwitz, Martin H. Prins3, Gary E. Raskob, Peter Verhamme, Philip S. Wells, Giancarlo Agnelli, Henri Bounameaux4, Alexander T. Cohen, Bruce Ritchie, Franco Piovella, Sebastian Schellong, Dominique Mottier5,6
1Department of Vascular Medicine
2Groupe de recherche sur la thrombose, pharmacologie des antithrombotiques et situations à risque
3Department of Epidemiology
4Service d'angiologie et d'hémostase
5Centre d’Investigation Clinique
6Groupe d'Etude de la Thrombose de Bretagne Occidentale

Tóm tắt

Từ khóa


Tài liệu tham khảo

Oger E, 2000, Thromb Haemost, 83, 657, 10.1055/s-0037-1613887

10.1111/j.1525-1497.2006.00458.x

Hutten BA, 2006, Cochrane Database Syst Rev, 1, CD001367

Prandoni P, 1996, Ann Intern Med, 125, 1, 10.7326/0003-4819-125-1-199607010-00001

10.1503/cmaj.080493

10.1378/chest.08-0658

10.1016/j.clpt.2005.06.011

10.1302/0301-620X.91B5.21691

10.1016/S0140-6736(09)60734-0

10.1182/blood-2008-05-160143

10.1161/CIRCULATIONAHA.106.668020

10.1056/NEJMoa064247

10.1056/NEJMsr077003

10.1007/978-3-642-00663-0_13

10.1056/NEJMoa0906598

10.1056/NEJMoa030104

10.1056/NEJMoa067703